サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1379332

体外診断用医薬品包装市場：製品別、エンドユーザー別-2023-2030年の世界予測

In-Vitro Diagnostics Packaging Market by Product (Bottles, Closures, Tubes), End User (Academic Institutes, Clinical Laboratories, Hospitals) - Global Forecast 2023-2030
出版日: | 発行: 360iResearch | ページ情報: 英文 188 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
体外診断用医薬品包装市場：製品別、エンドユーザー別-2023-2030年の世界予測
出版日: 2023年10月16日
発行: 360iResearch
ページ情報: 英文 188 Pages
納期: 即日から翌営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

体外診断用医薬品包装市場は、2022年の68億2,000万米ドルから2030年には114億4,000万米ドルに達すると予測され、予測期間中のCAGRは6.68%です。

体外診断用医薬品包装の世界市場

主な市場の統計
市場金額：基準年[2022] 68億2,000万米ドル
推定市場金額[2023] 72億4,000万米ドル
予測市場金額[2030] 114億4,000万米ドル
CAGR（%） 6.68%
体外診断用医薬品包装 Market-IMG1

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは体外診断用医薬品包装市場の評価に不可欠なツールです。事業戦略と製品満足度に関連する主要指標を分析し、ベンダーを包括的に評価します。これにより、ユーザーは特定のニーズに合わせた情報に基づいた意思決定を行うことができます。高度な分析により、ベンダーは4つの象限に分類され、それぞれ成功のレベルが異なります：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。この洞察に満ちたフレームワークにより、意思決定者は自信を持って市場をナビゲートすることができます。

市場シェア分析

市場シェア分析では、ベンダーの市場情勢に関する貴重な洞察を提供します。全体収益、顧客ベース、その他の主要指標への影響を評価することで、企業の業績と直面する競合環境を包括的に理解することができます。この分析では、調査期間中の市場シェア獲得、断片化、優位性、業界再編などの競合レベルも明らかにします。

本レポートは、以下の側面に関する貴重な洞察を提供しています：

1.市場の浸透度：主要企業の市場力学と製品に関する包括的な情報を提供します。

2.市場の開拓度：新興市場と成熟市場セグメントへの浸透度を詳細に分析し、有利なビジネスチャンスを浮き彫りにします。

3.市場の多様化：新製品の発売、未開拓の地域、最近の開発、投資に関する詳細情報。

4.競合の評価と情報：主要企業の市場シェア、戦略、製品、認証、規制状況、特許状況、製造能力を網羅的に評価。

5.製品開発およびイノベーション：将来の技術、研究開発活動、画期的な製品開発に関するインテリジェントな洞察。

本レポートは、以下のような主要な質問に対応しています：

1.体外診断用医薬品包装市場の市場規模および予測は？

2.体外診断用医薬品包装市場で最も高い投資ポテンシャルを持つ製品、セグメント、用途、分野は？

3.体外診断用医薬品包装市場における競争戦略の窓とは？

4.体外診断用医薬品包装市場の最新技術動向と規制の枠組みは？

5.体外診断用医薬品包装市場における主要ベンダーの市場シェアは？

6.体外診断用医薬品包装市場への参入に適した形態や戦略的手段は？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • 慢性疾患や感染症の蔓延
      • ポイントオブケア検査の増加傾向
      • 個別化医療アプローチへの傾向
    • 抑制要因
      • 体外診断用パッケージの製造コストが高い
    • 機会
      • 体外診断用スマートパッケージングのイントロダクション
      • 持続可能な体外診断用包装材の製造に向けた継続的な研究開発
    • 課題
      • 体外診断用パッケージの設計の複雑さ
  • 市場セグメンテーション分析
  • 市場動向分析
  • 高インフレの累積的影響
  • ポーターのファイブフォース分析
  • バリューチェーンとクリティカルパス分析
  • 規制の枠組み

第6章 体外診断用医薬品包装市場：製品別

  • ボトル
  • クロージャ
  • チューブ
  • バイアル

第7章 体外診断用医薬品包装市場：エンドユーザー別

  • 学術機関
  • 臨床検査室
  • 病院

第8章 南北アメリカの体外診断用医薬品包装市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第9章 アジア太平洋地域の体外診断用医薬品包装市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第10章 欧州・中東・アフリカの体外診断用医薬品包装市場

  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第11章 競合情勢

  • FPNVポジショニングマトリクス
  • 市場シェア分析：主要企業別
  • 競合シナリオ分析：主要企業別

第12章 競争力のあるポートフォリオ

  • 主要な企業プロファイル
    • Amcor PLC
    • APTARGROUP, INC.
    • Becton, Dickinson and Company
    • Bio-Rad Laboratories, Inc.
    • Corning Incorporated
    • DWK Life Sciences GmbH
    • DWK Life Sciences LLC
    • James Alexander Corporation
    • Narang Medical Limited
    • Oliver-Tolas Healthcare Packaging B.V.
    • PerkinElmer Inc.
    • PMMI Media Group
    • QIAGEN N.V.
    • Siemens AG
    • SONIC PACKAGING
    • Thermofisher Scientific Inc.
    • VITLAB GmbH
  • 主要な製品ポートフォリオ

第13章 付録

  • ディスカッションガイド
  • ライセンスと価格について
図表

LIST OF FIGURES

  • FIGURE 1. IN-VITRO DIAGNOSTICS PACKAGING MARKET RESEARCH PROCESS
  • FIGURE 2. IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, 2022 VS 2030
  • FIGURE 3. IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY REGION, 2022 VS 2030 (%)
  • FIGURE 5. IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY REGION, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 6. IN-VITRO DIAGNOSTICS PACKAGING MARKET DYNAMICS
  • FIGURE 7. IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2022 VS 2030 (%)
  • FIGURE 8. IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 9. IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2022 VS 2030 (%)
  • FIGURE 10. IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 11. AMERICAS IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
  • FIGURE 12. AMERICAS IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 13. UNITED STATES IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY STATE, 2022 VS 2030 (%)
  • FIGURE 14. UNITED STATES IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 15. ASIA-PACIFIC IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
  • FIGURE 16. ASIA-PACIFIC IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 19. IN-VITRO DIAGNOSTICS PACKAGING MARKET, FPNV POSITIONING MATRIX, 2022
  • FIGURE 20. IN-VITRO DIAGNOSTICS PACKAGING MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

  • TABLE 1. IN-VITRO DIAGNOSTICS PACKAGING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
  • TABLE 3. IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 6. IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY BOTTLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY CLOSURES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY TUBES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY VIALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 11. IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY ACADEMIC INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY CLINICAL LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. AMERICAS IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 15. AMERICAS IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 16. AMERICAS IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 17. ARGENTINA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 18. ARGENTINA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 19. BRAZIL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 20. BRAZIL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 21. CANADA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 22. CANADA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 23. MEXICO IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 24. MEXICO IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 25. UNITED STATES IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 26. UNITED STATES IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 27. UNITED STATES IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 28. ASIA-PACIFIC IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 29. ASIA-PACIFIC IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 30. ASIA-PACIFIC IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 31. AUSTRALIA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 32. AUSTRALIA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 33. CHINA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 34. CHINA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 35. INDIA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 36. INDIA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 37. INDONESIA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 38. INDONESIA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 39. JAPAN IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 40. JAPAN IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 41. MALAYSIA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 42. MALAYSIA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 43. PHILIPPINES IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 44. PHILIPPINES IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 45. SINGAPORE IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 46. SINGAPORE IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 47. SOUTH KOREA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 48. SOUTH KOREA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 49. TAIWAN IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 50. TAIWAN IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 51. THAILAND IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 52. THAILAND IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 53. VIETNAM IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 54. VIETNAM IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 55. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 56. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 57. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 58. DENMARK IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 59. DENMARK IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 60. EGYPT IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 61. EGYPT IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 62. FINLAND IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 63. FINLAND IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 64. FRANCE IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 65. FRANCE IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 66. GERMANY IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 67. GERMANY IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 68. ISRAEL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 69. ISRAEL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 70. ITALY IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 71. ITALY IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 72. NETHERLANDS IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 73. NETHERLANDS IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 74. NIGERIA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 75. NIGERIA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 76. NORWAY IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 77. NORWAY IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 78. POLAND IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 79. POLAND IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 80. QATAR IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 81. QATAR IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 82. RUSSIA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 83. RUSSIA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 84. SAUDI ARABIA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 85. SAUDI ARABIA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH AFRICA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH AFRICA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 88. SPAIN IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 89. SPAIN IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 90. SWEDEN IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 91. SWEDEN IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 92. SWITZERLAND IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 93. SWITZERLAND IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 94. TURKEY IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 95. TURKEY IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 96. UNITED ARAB EMIRATES IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 97. UNITED ARAB EMIRATES IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED KINGDOM IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED KINGDOM IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 100. IN-VITRO DIAGNOSTICS PACKAGING MARKET, FPNV POSITIONING MATRIX, 2022
  • TABLE 101. IN-VITRO DIAGNOSTICS PACKAGING MARKET SHARE, BY KEY PLAYER, 2022
  • TABLE 102. IN-VITRO DIAGNOSTICS PACKAGING MARKET LICENSE & PRICING
目次
Product Code: MRR-F6513A06BDC4

The In-Vitro Diagnostics Packaging Market is projected to reach USD 11.44 billion by 2030 from USD 6.82 billion in 2022, at a CAGR of 6.68% during the forecast period.

Global In-Vitro Diagnostics Packaging Market

KEY MARKET STATISTICS
Base Year Value [2022] USD 6.82 billion
Estimated Year Value [2023] USD 7.24 billion
Forecast Year Value [2030] USD 11.44 billion
CAGR (%) 6.68%
In-Vitro Diagnostics Packaging Market - IMG1

Market Segmentation & Coverage:

This research report analyzes various sub-markets, forecasts revenues, and examines emerging trends in each category to provide a comprehensive outlook on the In-Vitro Diagnostics Packaging Market.

Based on Product, market is studied across Bottles, Closures, Tubes, and Vials. The Closures is projected to witness significant market share during forecast period.

Based on End User, market is studied across Academic Institutes, Clinical Laboratories, and Hospitals. The Academic Institutes is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Europe, Middle East & Africa is projected to witness significant market share during forecast period.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is an indispensable tool for assessing the In-Vitro Diagnostics Packaging Market. It comprehensively evaluates vendors, analyzing key metrics related to Business Strategy and Product Satisfaction. This enables users to make informed decisions tailored to their specific needs. Through advanced analysis, vendors are categorized into four distinct quadrants, each representing a different level of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V). Be assured that this insightful framework empowers decision-makers to navigate the market with confidence.

Market Share Analysis:

The Market Share Analysis offers invaluable insights into the vendor landscape In-Vitro Diagnostics Packaging Market. By evaluating their impact on overall revenue, customer base, and other key metrics, we provide companies with a comprehensive understanding of their performance and the competitive environment they confront. This analysis also uncovers the level of competition in terms of market share acquisition, fragmentation, dominance, and industry consolidation during the study period.

Key Company Profiles:

The report delves into recent significant developments in the In-Vitro Diagnostics Packaging Market, highlighting leading vendors and their innovative profiles. These include Amcor PLC, APTARGROUP, INC., Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Corning Incorporated, DWK Life Sciences GmbH, DWK Life Sciences LLC, James Alexander Corporation, Narang Medical Limited, Oliver-Tolas Healthcare Packaging B.V., PerkinElmer Inc., PMMI Media Group, QIAGEN N.V., Siemens AG, SONIC PACKAGING, Thermofisher Scientific Inc., and VITLAB GmbH.

The report offers valuable insights on the following aspects:

1. Market Penetration: It provides comprehensive information about key players' market dynamics and offerings.

2. Market Development: In-depth analysis of emerging markets and penetration across mature market segments, highlighting lucrative opportunities.

3. Market Diversification: Detailed information about new product launches, untapped geographies, recent developments, and investments.

4. Competitive Assessment & Intelligence: Exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of leading players.

5. Product Development & Innovation: Intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast for the In-Vitro Diagnostics Packaging Market?

2. Which products, segments, applications, and areas hold the highest investment potential in the In-Vitro Diagnostics Packaging Market?

3. What is the competitive strategic window for identifying opportunities in the In-Vitro Diagnostics Packaging Market?

4. What are the latest technology trends and regulatory frameworks in the In-Vitro Diagnostics Packaging Market?

5. What is the market share of the leading vendors in the In-Vitro Diagnostics Packaging Market?

6. Which modes and strategic moves are suitable for entering the In-Vitro Diagnostics Packaging Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. In-Vitro Diagnostics Packaging Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing prevalence of chronic and infectious diseases
      • 5.1.1.2. Rising trend of point-of-care testing
      • 5.1.1.3. Inclination toward personalized medicine approach
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of production of in-vitro diagnostic packaging
    • 5.1.3. Opportunities
      • 5.1.3.1. Introduction of smart packaging for in-vitro diagnostics
      • 5.1.3.2. Ongoing R&D for the production of sustainable in-vitro diagnostic packaging
    • 5.1.4. Challenges
      • 5.1.4.1. Complexity in designing in-vitro diagnostic packaging
  • 5.2. Market Segmentation Analysis
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework

6. In-Vitro Diagnostics Packaging Market, by Product

  • 6.1. Introduction
  • 6.2. Bottles
  • 6.3. Closures
  • 6.4. Tubes
  • 6.5. Vials

7. In-Vitro Diagnostics Packaging Market, by End User

  • 7.1. Introduction
  • 7.2. Academic Institutes
  • 7.3. Clinical Laboratories
  • 7.4. Hospitals

8. Americas In-Vitro Diagnostics Packaging Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific In-Vitro Diagnostics Packaging Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa In-Vitro Diagnostics Packaging Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. FPNV Positioning Matrix
  • 11.2. Market Share Analysis, By Key Player
  • 11.3. Competitive Scenario Analysis, By Key Player

12. Competitive Portfolio

  • 12.1. Key Company Profiles
    • 12.1.1. Amcor PLC
    • 12.1.2. APTARGROUP, INC.
    • 12.1.3. Becton, Dickinson and Company
    • 12.1.4. Bio-Rad Laboratories, Inc.
    • 12.1.5. Corning Incorporated
    • 12.1.6. DWK Life Sciences GmbH
    • 12.1.7. DWK Life Sciences LLC
    • 12.1.8. James Alexander Corporation
    • 12.1.9. Narang Medical Limited
    • 12.1.10. Oliver-Tolas Healthcare Packaging B.V.
    • 12.1.11. PerkinElmer Inc.
    • 12.1.12. PMMI Media Group
    • 12.1.13. QIAGEN N.V.
    • 12.1.14. Siemens AG
    • 12.1.15. SONIC PACKAGING
    • 12.1.16. Thermofisher Scientific Inc.
    • 12.1.17. VITLAB GmbH
  • 12.2. Key Product Portfolio

13. Appendix

  • 13.1. Discussion Guide
  • 13.2. License & Pricing